American Society of Hematology

Fig. 2.

$Fig. 2. Morphology of sorted PBMCs from FL- or placebo-treated volunteers. / (A) CD11c+ CD14− DC fraction from an FL-treated individual. (B) CD11c+ CD14+monocyte fraction from an FL-treated individual. (C) CD11cdull CD14dull neutrophil fraction from an FL-treated individual. (D) CD11c+ CD14+monocyte fraction from a placebo-treated individual. Cytospins were prepared from the sorted PBMC populations depicted in Figure 1B and stained with Wright-Giemsa stain.$

Morphology of sorted PBMCs from FL- or placebo-treated volunteers.

(A) CD11c⁺ CD14⁻ DC fraction from an FL-treated individual. (B) CD11c⁺ CD14⁺monocyte fraction from an FL-treated individual. (C) CD11c^dull CD14^dull neutrophil fraction from an FL-treated individual. (D) CD11c⁺ CD14⁺monocyte fraction from a placebo-treated individual. Cytospins were prepared from the sorted PBMC populations depicted in Figure 1B and stained with Wright-Giemsa stain.

This Feature Is Available To Subscribers Only